Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Susan R S, Gottesman"'
Autor:
Diane, Wang, Charlotte L, Marous, Fatih, Ozay, Alisa, Timashpolsky, Rahul D, Gulati, Susan R S, Gottesman, Marina, Boruk, Roman, Shinder, Nickisa M, Hodgson
Publikováno v:
Orbit. :1-5
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of lymphoma, involving the lumen of predominantly small blood vessels, especially capillaries. The orbit is an uncommon site of involvement for IVLBCL, and diagnosis before autopsy is even m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b2e5d19c37868dcd1b3d90d0e57b85
https://doi.org/10.1080/01676830.2022.2034170
https://doi.org/10.1080/01676830.2022.2034170
Autor:
Anton V. Rets, Susan R. S. Gottesman
Publikováno v:
Case Reports in Pathology, Vol 2014 (2014)
Lymphomas with overlapping histological features of two distinct entities cause difficulty in classification. Their classification is of particular significance when the two alternatives require different treatment modalities. We present a diagnostic
Externí odkaz:
https://doaj.org/article/aea8cb027c6d4fda8586c4dff45093ff
Autor:
Irina Jilishitz, Scott Schoninger, Allison VanInwegen VanInwegen, Lingyue Yan, Jason Luis Quiñones, Stacy W. Blain, Grace Y. Chen, Jonathan Somma, Yun Wu, Jared Pasetsky, Vladislav Tsiperson, Manasi P. Jogalekar, Susan R. S. Gottesman, Priyank Patel
Publikováno v:
Molecular cancer research : MCR. 19(11)
Resistance to cyclin D-CDK4/6 inhibitors (CDK4/6i) represents an unmet clinical need and is frequently caused by compensatory CDK2 activity. Here we describe a novel strategy to prevent CDK4i resistance by using a therapeutic liposomal:peptide formul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::250c840a601d013f7f0fa89acade0dcf
https://pubmed.ncbi.nlm.nih.gov/34446542
https://pubmed.ncbi.nlm.nih.gov/34446542
Autor:
Grace Y. Chen, Jason Luis Quiñones, Irina Jilishitz, Jared Pavetsky, Susan R. S. Gottesman, Priyank Patel, Jonathan Somma, Lingyue Yan, Manasi P. Jogalekar, Vladislav Tsiperson, Scott Schoninger, Stacy W. Blain, Allison VanInwegen VanInwegen, Yun Wu
Publikováno v:
Cancer Research. 81:LB115-LB115
Resistance to cyclin D-cdk4/6 inhibitors (CDK4/6i) represents an unmet clinical need and is frequently caused by compensatory CDK2 activity. Here we describe a novel strategy to prevent CDK4i resistance by using a therapeutic liposomal:peptide formul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c60fb0e5f81c455dce41ad5799bdd3e
https://doi.org/10.1158/1538-7445.am2021-lb115
https://doi.org/10.1158/1538-7445.am2021-lb115
Autor:
Usha Govindarajulu, Jonathan Somma, Vladislav Tsiperson, Susan R. S. Gottesman, Priyank Patel, Lisa Dresner, Stacy W. Blain
Publikováno v:
Molecular cancer research : MCR. 17(3)
Cdk4-targeting drugs, such as palbociclib, are approved for metastatic ER/PR+, Her2− breast cancer. However, other than loss of retinoblastoma, which is very rare in this subset, there are no biomarkers to predict response. Cyclin D or cdk4 levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d78ff0f2484fa9daee267fc2a353a7d
https://pubmed.ncbi.nlm.nih.gov/30559257
https://pubmed.ncbi.nlm.nih.gov/30559257
Autor:
Ralf Wagner, Stacy W. Blain, Cindy Gomez, Angela L. Tyner, Priyank Patel, Benedikt Asbach, Susan R. S. Gottesman, Elina Shetyn
Publikováno v:
Cancer Research. 75:P5-08
The oncogenes Cyclin D and cdk4 are overexpressed in breast cancer, but the levels of these proteins are not always accurate indicators of oncogenic activity because p27Kip1 is required to assemble this otherwise unstable dimer. However, p27’s asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8c1c3ad583561aa576960a6e7ca8562
https://doi.org/10.1158/1538-7445.sabcs14-p5-08-01
https://doi.org/10.1158/1538-7445.sabcs14-p5-08-01
Publikováno v:
Molecular cancer research : MCR. 16(3)
Cyclin-dependent kinase 4/6 (CDK4/6)-specific inhibitors, such as palbociclib, have shown clinical efficacy, but primary or secondary resistance has emerged as a problem. To develop more effective therapeutic approaches, investigation is needed into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47aba095f7baf1d70ed4a33dadcb125a
https://pubmed.ncbi.nlm.nih.gov/29330290
https://pubmed.ncbi.nlm.nih.gov/29330290
Autor:
Jinjuan Yao, Albert S. Braverman, Constantine A. Axiotis, Susan R. S. Gottesman, Getinet Ayalew
Publikováno v:
American Journal of Surgical Pathology. 37:1407-1412
Adult T-cell leukemia/lymphoma (ATLL) is caused by the HTLV-1 virus, endemic to Japan and the Caribbean, and is likely derived from cells with the T-regulatory phenotype. The malignant cells express IL2 receptor α (CD25), and the majority express tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53a052e67dcbb699574db467f3caa64
https://doi.org/10.1097/pas.0b013e31828f2322
https://doi.org/10.1097/pas.0b013e31828f2322
Autor:
Hongjie Li, Susan R. S. Gottesman
Publikováno v:
American Journal of Clinical Pathology. 149:S84-S84
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfaede272a02c065a7545cd959dd9fcf
https://doi.org/10.1093/ajcp/aqx121.196
https://doi.org/10.1093/ajcp/aqx121.196
Autor:
Karen M. Samanich, Joanne Edington, Susan R. S. Gottesman, G. Jeanette Thorbecke, Christina D. Swenson, Donald V. Belsito
Publikováno v:
Annals of the New York Academy of Sciences. 774:249-258
IgD-receptors are associated with augmented antibody production in vivo and are induced on CD4+ T cells by aggregated IgD in young but not in aged mice. In the current study orally or intraperitoneally administered DHEAS was found to enhance antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::417f304d5bcb91142b5c7cee680a846f
https://doi.org/10.1111/j.1749-6632.1995.tb17385.x-i1
https://doi.org/10.1111/j.1749-6632.1995.tb17385.x-i1